JP2024510267A5 - - Google Patents
Info
- Publication number
- JP2024510267A5 JP2024510267A5 JP2023556985A JP2023556985A JP2024510267A5 JP 2024510267 A5 JP2024510267 A5 JP 2024510267A5 JP 2023556985 A JP2023556985 A JP 2023556985A JP 2023556985 A JP2023556985 A JP 2023556985A JP 2024510267 A5 JP2024510267 A5 JP 2024510267A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- isotope
- metal
- magnetic resonance
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163200593P | 2021-03-16 | 2021-03-16 | |
| US202163200592P | 2021-03-16 | 2021-03-16 | |
| US202163161835P | 2021-03-16 | 2021-03-16 | |
| US63/161,835 | 2021-03-16 | ||
| US63/200,592 | 2021-03-16 | ||
| US63/200,593 | 2021-03-16 | ||
| US202163165583P | 2021-03-24 | 2021-03-24 | |
| US202163165550P | 2021-03-24 | 2021-03-24 | |
| US202163165563P | 2021-03-24 | 2021-03-24 | |
| US63/165,563 | 2021-03-24 | ||
| US63/165,583 | 2021-03-24 | ||
| US63/165,550 | 2021-03-24 | ||
| PCT/US2022/020084 WO2022197567A1 (en) | 2021-03-16 | 2022-03-12 | Compounds targeting fibroblast-activation protein and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510267A JP2024510267A (ja) | 2024-03-06 |
| JP2024510267A5 true JP2024510267A5 (enExample) | 2025-03-21 |
Family
ID=83320754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556985A Pending JP2024510267A (ja) | 2021-03-16 | 2022-03-12 | 線維芽細胞活性化タンパク質を標的とする化合物、およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240238458A1 (enExample) |
| EP (1) | EP4308110A4 (enExample) |
| JP (1) | JP2024510267A (enExample) |
| CA (1) | CA3212210A1 (enExample) |
| TW (1) | TW202300143A (enExample) |
| WO (1) | WO2022197567A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI879182B (zh) * | 2023-10-26 | 2025-04-01 | 國家原子能科技研究院 | 白蛋白雙重結合功能之纖維母細胞活化蛋白化合物或其鹽 |
| WO2025155818A1 (en) * | 2024-01-19 | 2025-07-24 | Purdue Research Foundation | Fibroblast activation protein-targeted radioligands with pharmacokinetic modulators |
| WO2025171343A1 (en) * | 2024-02-08 | 2025-08-14 | Immunome, Inc. | Compounds targeting fibroblast-activation protein and methods of use thereof |
| CN118593732B (zh) * | 2024-06-27 | 2025-03-11 | 华中科技大学同济医学院附属同济医院 | 一种心肌炎核素分子探针及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7399869B2 (en) * | 2005-05-19 | 2008-07-15 | Genentech, Inc. | Fibroblast activation protein inhibitor compounds and methods |
| US8071787B2 (en) * | 2009-03-13 | 2011-12-06 | National Health Research Institutes | Pyrrolidine compounds |
| CN106573073B (zh) * | 2014-06-13 | 2021-09-28 | 塔夫茨大学信托人 | Fap激活的治疗剂以及其相关用途 |
| CN116474108A (zh) * | 2016-12-14 | 2023-07-25 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)-靶向成像和治疗 |
| HRP20230604T1 (hr) * | 2018-03-30 | 2023-09-29 | Futurechem Co., Ltd. | Radiofarmaceutik usmjeren na psma, namijenjen dijagnosticiranju i liječenju raka prostate |
| US11426472B2 (en) * | 2018-10-17 | 2022-08-30 | Purdue Research Foundation | Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis |
| SG11202109761TA (en) * | 2019-04-03 | 2021-10-28 | Tarveda Therapeutics Inc | Hsp90-binding conjugates and formulations thereof |
| WO2021016392A1 (en) * | 2019-07-22 | 2021-01-28 | Purdue Research Foundation | Multivalent fibroblast-targeted agents and methods of use |
-
2022
- 2022-03-12 JP JP2023556985A patent/JP2024510267A/ja active Pending
- 2022-03-12 US US18/550,964 patent/US20240238458A1/en active Pending
- 2022-03-12 WO PCT/US2022/020084 patent/WO2022197567A1/en not_active Ceased
- 2022-03-12 CA CA3212210A patent/CA3212210A1/en active Pending
- 2022-03-12 EP EP22771974.7A patent/EP4308110A4/en active Pending
- 2022-03-15 TW TW111109356A patent/TW202300143A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510267A5 (enExample) | ||
| JP7630149B2 (ja) | Ｐｓｍａを標的としたイメージング及び放射線治療のための金属／放射性金属標識ｐｓｍａ阻害剤 | |
| JP7059372B2 (ja) | デュアルモードの放射性トレーサーおよび療法剤 | |
| JP7449864B2 (ja) | エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用 | |
| JP2833766B2 (ja) | アミノポリカルボン酸およびその誘導体 | |
| JP2022548155A5 (enExample) | ||
| US11401262B2 (en) | Dimeric contrast agents | |
| TW319763B (enExample) | ||
| JP2024514528A5 (enExample) | ||
| JP2854159B2 (ja) | ジエチレントリアミンペンタ酢酸−モノアミド及びその錯体及び錯塩、その製法、これを含有するｎｍｒ−、レントゲン−及び放射線−診断剤並びに放射線−又は射線療法剤及びその薬剤の製法 | |
| JP2022518956A (ja) | がん診断用画像化剤 | |
| JP3250220B2 (ja) | マルチサイト金属キレート化剤 | |
| JP2020518673A5 (enExample) | ||
| RU2019139432A (ru) | Фармакокинетическая оптимизация бифункциональных хелатов и их применение | |
| CN113166054A (zh) | 成像剂 | |
| JPH11510834A (ja) | カスケードポリマー錯体、その製造方法及びこれらを含有する医薬 | |
| US11007283B2 (en) | Contrast agents | |
| TW202302542A (zh) | 化合物及放射性標誌化合物 | |
| JP7145156B2 (ja) | 二量体造影剤 | |
| JPH02196761A (ja) | オルト結合官能性を有するキレート剤類およびそれらの錯塩類 | |
| JP5503149B2 (ja) | 二官能性ポリアザ大環状キレート剤 | |
| JPH09512004A (ja) | キレート化剤化合物 | |
| JP2020532538A5 (enExample) | ||
| CN112601740B (zh) | 用于治疗黑素瘤的放射性化合物及其用途 | |
| US5616312A (en) | Thiol ligands and complexes for X-ray imaging |